We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Improvement in symptom-related disruptions is associated with fewer days of short-acting beta-agonist use in asthma.
- Authors
Kaye, Leanne; Vuong, Vy; Barrett, Meredith A.; Boers, Elroy; Guilbert, Theresa
- Abstract
Significant indirect healthcare costs are related to uncontrolled asthma, including productivity loss. Days with short-acting beta-agonist (SABA) use is associated with symptom-related disruptions at work, home, and school. Digital self-management platforms may support fewer days with SABA medication use and may reduce symptom-related disruptions.
- Subjects
ASTHMA treatment; SYMPTOMS; ADRENERGIC beta agonists; DIGITAL technology; DRUG utilization
- Publication
NPJ Primary Care Respiratory Medicine, 2022, Vol 32, Issue 1, p1
- ISSN
2055-1010
- Publication type
Article
- DOI
10.1038/s41533-022-00299-3